BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 17, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Quorum sensing controls adaptive immunity via CRISPR

Nov. 23, 2016
By John Fox
Most of the attention lavished on CRISPR is about its capacity to edit mammalian genes, but a study by New Zealand researchers has given new insight into the functions of CRISPR in bacteria.
Read More

Quorum sensing controls adaptive immunity via CRISPR

Nov. 22, 2016
By John Fox
Most of the attention lavished on CRISPR is about its capacity to edit mammalian genes, but a study by New Zealand researchers has given new insight into the functions of CRISPR in bacteria.
Read More

Tau phosphorylation inhibits plaque toxicity in AD mice

Nov. 18, 2016
By John Fox
HONG KONG – Researchers at the University of New South Wales (UNSW) in Sydney, have established that site-specific phosphorylation of tau protein inhibits amyloid beta (Abeta) plaque toxicity in mice with Alzheimer's disease (AD), providing valuable new insights into AD pathogenesis that could potentially result in new treatments.
Read More

Drug shows promise in preventing pre-term birth in mice

Nov. 16, 2016
By John Fox
HONG KONG – Australian researchers at the University of Adelaide's Robinson Research Institute (RRI) have successfully tested a drug showing early promise for preventing pre-term birth in mice, by suppressing inflammatory mechanisms underlying premature delivery.
Read More

Drug shows promise in preventing pre-term birth in mice

Nov. 15, 2016
By John Fox
HONG KONG – Australian researchers at the University of Adelaide’s Robinson Research Institute (RRI) have successfully tested a drug showing early promise for preventing pre-term birth in mice, by suppressing inflammatory mechanisms underlying premature delivery.
Read More

Bacterial metabolite shows activity in breast cancer

Nov. 9, 2016
By John Fox
HONG KONG – The bacterial metabolite prodigiosin and its analogue, obatoclax, have been shown to have therapeutic activity in advanced breast cancer, providing the rationale for clinical trials, Chinese researchers reported in the Oct. 31, 2016, online edition of Proceedings of the National Academy of Sciences.
Read More

Bacterial metabolite shows activity in breast cancer

Nov. 9, 2016
By John Fox
HONG KONG — The bacterial metabolite prodigiosin and its analogue, obatoclax, have been shown to have therapeutic activity in advanced breast cancer, providing the rationale for clinical trials, Chinese researchers reported in the Oct. 31, 2016, online edition of Proceedings of the National Academy of Sciences.
Read More

Worm protein shown to be effective against asthma

Nov. 2, 2016
By John Fox
An Australian study has identified a protein secreted by parasitic hookworms that suppresses asthma in mice, with in vitro tests on cells from asthmatics indicating that the protein is a promising candidate for development of new anti-inflammatory treatments.
Read More

Worm protein shown to be effective against asthma

Nov. 1, 2016
By John Fox
An Australian study has identified a protein secreted by parasitic hookworms that suppresses asthma in mice, with in vitro tests on cells from asthmatics indicating that the protein is a promising candidate for development of new anti-inflammatory treatments.
Read More

Starving stem cells aids safer transplantation

Oct. 26, 2016
By John Fox
HONG KONG – Scientists in Japan have identified an essential amino acid that is vital for the maintenance of hematopoietic stem cells (HSCs) in mice. That is a key finding that may lead to the development of a safer, more targeted pre-treatment regimen for bone marrow transplantation (BMT) in humans and possibly even a new approach to cancer therapy.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 16, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Senior medical exam

    Celia trial: data strong, analysts skeptical

    BioWorld
    Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • Illustration of human brain and dna

    Voyager’s gene therapy reduces tau levels in AD models

    BioWorld Science
    At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing